<DOC>
	<DOCNO>NCT00882466</DOCNO>
	<brief_summary>The purpose study investigate effect intravenous human recombinant erythropoietin reperfusion injury primary percutaneous coronary intervention patient acute myocardial infarction .</brief_summary>
	<brief_title>The Effect Erythropoietin Time Reperfusion Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Acute myocardial infarction &lt; 12hr Age &gt; 18yrs First myocardial infarction culprit lesion : proximal mid leave anterior descend artery Baseline coronary flow : TIMI Grade 0~1 Patients previous myocardial infarction History thrombotic complication History cerebral infarction Uncontrolled hypertension Increased hemoglobin level &gt; 17g/dL Patients mechanical valve Cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>erythropoietin</keyword>
</DOC>